Clinical Pathway for Alzheimer's Disease in China (CPAD)

This study has been completed.
Sponsor:
Collaborator:
Beijing Novartis Pharma
Information provided by (Responsible Party):
Huali Wang, Peking University
ClinicalTrials.gov Identifier:
NCT01779310
First received: January 24, 2013
Last updated: April 23, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)